Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: Biological roles and effects of TNF and TNF antagonists

Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis

(2010) Antonio Diez-Ruiz et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease

(2009) G. FIORINO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn’s disease after failure of two other anti-TNF antibodies

(2009) M. ALLEZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor

(2009) Zehra Kaymakcalan et al.   CLINICAL IMMUNOLOGY

Differences in binding and effector functions between classes of TNF antagonists

(2009) Taruna Arora et al.   CYTOKINE

Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis

(2009) C Coquerelle et al.   GUT

Blocking CD27-CD70 Costimulatory Pathway Suppresses Experimental Colitis

(2009) M. Manocha et al.   JOURNAL OF IMMUNOLOGY

Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis

(2009) Yasunori Kageyama et al.   Modern Rheumatology

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study

(2009) D. Fouache et al.   RHEUMATOLOGY

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

(2008) Hiroki Mitoma et al.   ARTHRITIS AND RHEUMATISM

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

(2008) J. Schmitt et al.   BRITISH JOURNAL OF DERMATOLOGY

TL1A (TNFSF15) Regulates the Development of Chronic Colitis by Modulating Both T-Helper 1 and T-Helper 17 Activation

(2008) Hidetoshi Takedatsu et al.   GASTROENTEROLOGY

A crucial role for HVEM and BTLA in preventing intestinal inflammation

(2008) Marcos W. Steinberg et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

(2008) Clare A. Notley et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis

(2007) Y. Ito et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Focus on adverse events of tumour necrosis factor   blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

(2007) V Gerloni et al.   ANNALS OF THE RHEUMATIC DISEASES

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS